Segment Data (Tables)

3 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

Financial Information for Company's Segments

Financial information for the Company’s segments was as follows:

	Three Months Ended December 31,
(Millions of dollars)	2015				2014
Revenues (A)
Medical	$	2,054			$	1,072
Life Sciences	933				979
Total Revenues	$	2,986			$	2,051
Segment Operating Income
Medical	$	465		(B)	$	304
Life Sciences	202				214
Total Segment Operating Income	667				517
Unallocated Items (C)	(401		)		(232		)
Income Before Income Taxes	$	266			$	285

(A) Intersegment revenues are not material.

(B) Includes an increase of $136 million in non-cash amortization expense relating to the identifiable intangible assets acquired in the CareFusion transaction as well as depreciation expense relating to the fixed assets acquired in the CareFusion transaction.

(C) Includes primarily interest, net; foreign exchange; corporate expenses; and share-based compensation expense. Also includes acquisition-related costs associated with the CareFusion transaction.

Revenues by Geographic Areas

Revenues by geographic areas were as follows:

	Three Months Ended December 31,
(Millions of dollars)	2015		2014
Revenues
United States	$	1,691	$	881
International	1,295		1,170
Total Revenues	$	2,986	$	2,051